Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters

被引:37
作者
Hedberg, Y
Roos, G
Ljungberg, B
Landberg, G [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Div Pathol, SE-20502 Malmo, Sweden
[2] Umea Univ, Dept Med Biosci Pathol, Umea, Sweden
[3] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden
关键词
D O I
10.1080/028418602753669562
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aberrations in the G1/S checkpoint are common in malignancies and are probably important for tumor development. Few G1/S studies have been performed on renal cell carcinoma (RCC) and therefore in this study the cyclin D3 protein content in 80 RCCs and that in 12 corresponding normal kidney cortex tissues are characterized using Western blotting. High cyclin D3 protein content was observed in 16% of the tumors and was significantly associated with aneuploidy, high TNM stage, high nuclear grade, high proliferation and young age. There was no association between tumor cyclin D3 and patient survival. The cyclin D3 overexpression was confirmed by immunohistochemical staining of 72 tumors, showing both nuclear and cytoplasmic localization of cyclin D3 in a fraction of the tumors. The cyclin D1 content has earlier been characterized in this tumor material and there was no relation between cyclin D1 and cyclin D3 protein expression. In summary, a fraction of the tumors overexpressed cyclin D3, supporting that various aberrations in the G1/S transition are implicated in RCCs.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 31 条
  • [1] Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells
    Baldassarre, G
    Belletti, B
    Bruni, P
    Boccia, A
    Trapasso, F
    Pentimalli, F
    Barone, MV
    Chiappetta, G
    Vento, MT
    Spiezia, S
    Fusco, A
    Viglietto, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07) : 865 - 874
  • [2] Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation
    Bartkova, J
    Lukas, J
    Strauss, M
    Bartek, J
    [J]. ONCOGENE, 1998, 17 (08) : 1027 - 1037
  • [3] Bartkova J, 1996, INT J CANCER, V65, P323, DOI 10.1002/(SICI)1097-0215(19960126)65:3<323::AID-IJC8>3.0.CO
  • [4] 2-1
  • [5] BUDILLON A, 1995, CANCER, V76, P1869, DOI 10.1002/1097-0142(19951115)76:10<1869::AID-CNCR2820761030>3.0.CO
  • [6] 2-B
  • [7] Doglioni C, 1998, J PATHOL, V185, P159, DOI 10.1002/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO
  • [8] 2-0
  • [9] CYCLINS AS MARKERS OF TUMOR PROLIFERATION - IMMUNOCYTOCHEMICAL STUDIES IN BREAST-CANCER
    DUTTA, A
    CHANDRA, R
    LEITER, LM
    LESTER, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5386 - 5390
  • [10] GRANA X, 1995, ONCOGENE, V11, P211